DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Antifungal infection Therapeutics Market Analysis & Trends - Drug Type (Allylamines, Polyenes, Echinocandins and Azoles) - Forecast to 2025" report to their offering.
Some of the prominent trends that the market is witnessing include huge number of infections are caused by aspergillus and candida fungus, introduction of new drugs, recent technological developments of antifungal infection therapeutics and growth opportunities/investment opportunities.
Based on drug type the market is categorized into allylamines, polyenes, echinocandins and azoles.
This industry report analyzes the global markets for Antifungal infection Therapeutics across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
- Abbott Laboratories
- Astellas Pharma Inc.
- Bayer Healthcare
- Enzon Pharmaceuticals
- Kramer Laboratories
- Merck & Co.
- SCYNEXIS Inc.
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
4 Antifungal infection Therapeutics Market, By Drug Type
5 Antifungal infection Therapeutics Market, By Geography
6 Key Player Activities
7 Leading Companies
For more information about this report visit http://www.researchandmarkets.com/research/l2ps9g/global_antifungal